Subcutaneous Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis.
Achille MarinoLuca MarelliPaolo NucciRoberto Felice CaporaliElisabetta MiserocchiPublished in: Ocular immunology and inflammation (2023)
SC-TCZ can be effective and safe in patients with JIA and uveitis recalcitrant to several bDMARDs.